(19)
(11) EP 4 562 157 A1

(12)

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23847573.5

(22) Date of filing: 27.07.2023
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
C12N 15/11(2006.01)
C12Q 1/6876(2018.01)
A61K 31/713(2006.01)
C12Q 1/68(2018.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; A61K 31/713; C12N 2310/113; A61P 37/00
(86) International application number:
PCT/US2023/071135
(87) International publication number:
WO 2024/026418 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 28.07.2022 US 202263393228 P

(71) Applicant: New York University
New York, NY 10012 (US)

(72) Inventors:
  • MOORE, Kathryn J.
    Westfield, NJ 07090 (US)
  • VAN SOLINGEN, Coen
    New York, NY 10026 (US)
  • CYR, Yannick
    New York, NY 10016 (US)

(74) Representative: FRKelly 
Waterways House Grand Canal Quay
Dublin D02 PD39
Dublin D02 PD39 (IE)

   


(54) TARGETING LONG NON-CODING RNA CHROMR IN INTERFERON-MEDIATED INFLAMMATION IN HUMANS